At-Home Transcutaneous Tibial Nerve Stimulation for Overactive Bladder in Rural Women
Part of paid clinical trials in Portland, Oregon.
- Sponsor
- Oregon Health and Science University
- Study ID
- NCT07178314
- Status
- Recruiting
Conditions
- Overactive Bladder
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Transcutaneous Tibial Nerve Stimulation (TTNS) — DEVICEParticipants will perform self-implemented at-home transcutaneous tibial nerve stimulation using a transcutaneous electrical nerve stimulation (TENS) unit. Participants will be instructed to use the TENS unit to deliver stimulation to the tibial nerve on one ankle for a 30-minute session, three times per week for 12 weeks upon receipt of the device. Intensity will be based on the participant's tolerance, just above the perception threshold but not painful.
Study Details
This study contains a mixed-methods design consisting of a single-arm, interventional study and prospective patient interviews evaluating a novel self-implemented at-home Transcutaneous Tibial Nerve Stimulation (TTNS) treatment protocol for management of treatment naïve overactive bladder (OAB) among rural-dwelling women. This study will be conducted in 3 rural Oregon communities where Oregon Health \& Science University satellite campuses are located.
Key Dates
- Start date
- Oct 6, 2025
- Status verified
- Oct 2025
- Primary completion
- Oct 31, 2026
- Completion
- Oct 31, 2026
Study Design
- Enrollment
- 38 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Rural Women Treated with Transcutaneous Tibial Nerve StimulationParticipants will undergo a self-implemented at-home Transcutaneous Tibial Nerve Stimulation (TTNS) treatment protocol for management of treatment naive overactive bladder (OAB) among rural dwelling women.
Primary Outcome Measure
Overactive Bladder questionnaire short form (OAB-q SF) Health-related Quality of life [ Time Frame: Evaluated upon enrollment and following 12 weeks of intervention ]
Central Contacts
- Women's Health Research Unit Department of Ob/Gyn503-494-3666
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Oregon Health & Science University | Portland | Oregon | 97239 |
Find similar trials in Portland, OR
By research site
Related Studies
- A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)Recruiting · Valencia Technologies Corporation · Homewood, Alabama
- Standard Injections Versus Reduced Injections for Intravesical onabotulinumtoxinA Treatment of Overactive BladderPHASE4 · Recruiting · Walter Reed National Military Medical Center · Bethesda, Maryland
- Fluoroscopy Radiation Reduction During Sacral Neuromodulation Lead PlacementRecruiting · Loma Linda University · Loma Linda, California
- Antibiotic Usage Prior to OnabotulinumtoxinA InjectionRecruiting · Benaroya Research Institute · Stony Brook, New York